Figure 1 - Antiviral therapeutics market.

From the following article

Antivirals become a broader enterprise

Jeffrey L Fox

Nature Biotechnology 25, 1395 - 1402 (2007)

doi:10.1038/nbt1207-1395

BACK TO ARTICLE
Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, or to obtain a text description, please contact npg@nature.com

(a) Antivirals garner the largest share of the market (54%, $18 billion), with vaccines (30%, $19 billion) and mAbs (6%, $2 billion) getting smaller shares. (Source: Jain KK. Antiviral Therapeutics. Jain PharmaBiotech Publications, Basel, November 2007.) (b) 2006 US market share of anti-viral agents by indication (excluding HIV). (Source: Arrowhead Publications, Minneapolis, MN.)

Figures and tables index
BACK TO ARTICLE